The tobacco sector has staged a massive comeback in recent months. Imperial Brands in particular has gained almost 60% since the October 2023 rout. In this update, I take a fresh look at the valuation of IMBBY stock and compare it with its peers British American Tobacco, Altria Group, and Philip Morris International. I give reasons for the valuation differences and explain where I still see value in the tobacco sector.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
IMMBY has proven that a smaller and focused market strategy allows it to survive the uncertain secular tobacco decline and slower New Generation Product monetization. Given its ability to grow tobacco share in priority markets while expanding profitability, the management has been able to return great value to long-term shareholders through share repurchases/ dividends. Combined with IMBBY's inherent undervaluation compared to its peers/ historical means, we believe that opportunistic investors may look forward to further capital appreciation ahead.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Imperial Brands has seen notable performance in the stock market over the past year, driven by its sustained performance, attractive market multiples and high dividend yield. Its recent results for H1 FY24 impressed investors, with strong pricing power and steady improvement in the share of its in next-generation products in revenues. Despite a higher than average price rise, its forward P/E and healthy dividend growth make it an attractive investment option with potential for further price rise.